Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
Clinical trial NCT04581382 · COMPLETED
Trial details
- NCT number
- NCT04581382
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2024-10-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.